Abstract

Diabetes has long been acknowledged as a risk factor for adverse outcome in cardiac surgery. However, results regarding the influence of various levels of perioperative glycaemic control on outcome are inconsistent, not to mention that it has been mainly tested in surgeries requiring cardiopulmonary bypass, a major confounder of glycaemic control. Glycated haemoglobin (HBA1c) indicates the degree of glycaemic control over the last 3 months, which would be a better predictor of outcome. We evaluated the impact of preoperative HbA1c in diabetic patients on perioperative glycaemic variability and outcome after OPCAB.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call